v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Statement of Cash Flows [Abstract]    
Net cash provided by (used in) operating activities $ 1,854 $ 1,565
Cash flows from investing activities    
Sales, maturities and repayments of fixed maturity securities available-for-sale 12,714 7,161
Sales, maturities and repayments of equity securities 3 6
Sales, maturities and repayments of mortgage loans 3,060 2,568
Sales, maturities and repayments of real estate and real estate joint ventures 70 50
Sales, maturities and repayments of other limited partnership interests 225 240
Sales, maturities and repayments of short-term investments 1,974 2,494
Purchases of fixed maturity securities available-for-sale (14,196) (9,448)
Purchases of equity securities (87) (33)
Purchases of mortgage loans (2,659) (1,381)
Purchases of real estate and real estate joint ventures (346) (87)
Purchases of other limited partnership interests (164) (101)
Purchases of short-term investments (1,147) (2,576)
Cash received in connection with freestanding derivatives 384 489
Cash paid in connection with freestanding derivatives (620) (575)
Net change in policy loans 51 (92)
Net change in other invested assets (173) 332
Other, net 79 24
Net cash provided by (used in) investing activities (832) (929)
Cash flows from financing activities    
Policyholder account balances - deposits 19,573 21,763
Policyholder account balances - withdrawals (19,100) (22,366)
Net change in payables for collateral under securities loaned and other transactions 890 277
Long-term debt repaid (50) 0
Derivatives with certain financing elements and other derivative-related transactions, net 3 11
Dividends paid to MetLife, Inc. (1,309) (1,365)
Other, net (3) (46)
Net cash provided by (used in) financing activities 4 (1,726)
Effect of change in foreign currency exchange rates on cash and cash equivalents balances (2) 1
Change in cash and cash equivalents 1,024 (1,089)
Cash and cash equivalents, beginning of period 8,392 7,271
Cash and cash equivalents, end of period 9,416 6,182
Supplemental disclosures of cash flow information    
Net cash paid for Interest 5 7
Net cash paid (received) for Income tax 1 39
Non-cash transactions:    
Other invested assets received in connection with the sale of other limited partnership interests 269 17
Increase in fair value option securities 816 0
Increase in notes issued by collateralized financing entities $ 801 $ 0